Bank of New York Mellon Corp - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$84,964
+27.9%
88,504
-0.1%
0.00%
Q1 2023$66,434
+103.5%
88,5790.0%0.00%
Q4 2022$32,641
-14.1%
88,579
-0.1%
0.00%
Q3 2022$38,000
-44.9%
88,662
+1.0%
0.00%
Q2 2022$69,000
-89.2%
87,751
-82.3%
0.00%
Q1 2022$640,000
-62.6%
496,150
-63.2%
0.00%
Q4 2021$1,710,000
-42.9%
1,347,653
-1.9%
0.00%
-100.0%
Q3 2021$2,994,000
-39.2%
1,373,688
+4.6%
0.00%0.0%
Q2 2021$4,923,000
+3.9%
1,313,019
-9.7%
0.00%0.0%
Q1 2021$4,740,000
-8.3%
1,453,890
-4.1%
0.00%0.0%
Q4 2020$5,168,000
-15.6%
1,515,338
+1.0%
0.00%
-50.0%
Q3 2020$6,123,000
+44.5%
1,500,686
+19.7%
0.00%
+100.0%
Q2 2020$4,238,000
+53.1%
1,253,849
+5.5%
0.00%0.0%
Q1 2020$2,769,000
-39.7%
1,188,763
-5.8%
0.00%0.0%
Q4 2019$4,594,000
-54.5%
1,262,018
+3.8%
0.00%
-66.7%
Q3 2019$10,089,000
-3.2%
1,216,331
+0.4%
0.00%0.0%
Q2 2019$10,426,000
-18.0%
1,210,987
+1.8%
0.00%
-25.0%
Q1 2019$12,714,000
+25.8%
1,189,260
+3.0%
0.00%
+33.3%
Q4 2018$10,103,000
-48.0%
1,154,661
-0.1%
0.00%
-40.0%
Q3 2018$19,423,000
-16.2%
1,156,085
+4.5%
0.01%
-16.7%
Q2 2018$23,180,000
+34.4%
1,105,928
+3.2%
0.01%
+20.0%
Q1 2018$17,246,000
-13.2%
1,071,858
+2.2%
0.01%0.0%
Q4 2017$19,877,000
+53.7%
1,048,890
+14.1%
0.01%
+25.0%
Q3 2017$12,935,000
+94.3%
919,334
+2.9%
0.00%
+100.0%
Q2 2017$6,658,000
+6.9%
893,692
-6.7%
0.00%0.0%
Q1 2017$6,227,000
+51.9%
958,006
+3.5%
0.00%
+100.0%
Q4 2016$4,099,000
+3.3%
925,529
+9.0%
0.00%0.0%
Q3 2016$3,967,000
-21.9%
849,335
+9.8%
0.00%
-50.0%
Q2 2016$5,080,000
-0.5%
773,223
-3.6%
0.00%0.0%
Q1 2016$5,103,000
+7.3%
802,311
+1.7%
0.00%
+100.0%
Q4 2015$4,758,000
-0.1%
789,020
-0.9%
0.00%0.0%
Q3 2015$4,761,000
-0.1%
796,066
+14.3%
0.00%0.0%
Q2 2015$4,764,000
+30.7%
696,355
+16.0%
0.00%0.0%
Q1 2015$3,644,000
-10.3%
600,223
+2.4%
0.00%0.0%
Q4 2014$4,061,000
-16.3%
586,043
-1.7%
0.00%0.0%
Q3 2014$4,854,000
-47.1%
596,260
-47.2%
0.00%0.0%
Q2 2014$9,184,000
+111.0%
1,129,848
+103.5%
0.00%0.0%
Q1 2014$4,353,000
-13.3%
555,265
-2.2%
0.00%0.0%
Q4 2013$5,022,000
-51.1%
567,487
-53.7%
0.00%
-50.0%
Q3 2013$10,272,000
+133.0%
1,225,732
+107.4%
0.00%
+100.0%
Q2 2013$4,408,000591,0250.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders